Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart BDR | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$4.23T | 40.5x | 93.71 | R$33.14 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger Co | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$264.77B | 19.6x | 0.77 | R$400.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$208.68B | 18.2x | -3.49 | R$217.14 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano DRC | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$189.47B | 24.3x | 0.51 | R$548 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RAIADROGASIL ON | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$23.52B | 19.5x | 1.48 | R$13.72 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.4% Upside | Upgrade to Pro+ | |
Grupo Mateus | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$17.74B | 12.6x | 0.93 | R$7.79 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$13.77B | 17.9x | 0.92 | R$10.04 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
Pague Menos | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$2.13B | 48.4x | 1.34 | R$3.43 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Brasileira De Dist | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.73B | -1.2x | -0.02 | R$3.82 | 8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.6% Downside | Upgrade to Pro+ | |
Dimed | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.42B | 13.5x | -1.21 | R$9.43 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.3% Upside | Upgrade to Pro+ | |
D1000 On | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$239.86M | 10.8x | 2.42 | R$4.78 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.7% Upside | Upgrade to Pro+ |